Sponsor Pipeline

Sandoz Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06847724 Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab… Relapsing Multiple Sclerosis Active, Not Recruiting
Not specified
NCT05633771 Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®)… Inflammatory Bowel Disease Active, Not Recruiting
Disease Areas
Multiple Sclerosis (1)
Get alerts when Sandoz's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free